TOP 10 COMPANIES IN REMOTE PATIENT MONITORING MARKET

The Remote Patient Monitoring Market is expected to grow at a CAGR of 13.7% from 2024 to 2031 to reach $116.84 billion by 2031, according to Meticulous Research®. The growth of this market is mainly driven by the increasing geriatric population, rising prevalence of chronic diseases, the global shortage of healthcare professionals, growing awareness regarding the benefits of RPM, such as convenience and improved patient outcomes, rising need to reduce healthcare costs, and favorable government initiatives promoting remote patient monitoring are the factors driving the growth of the remote patient monitoring market. Additionally, technological advancements in telehealth & remote patient monitoring, emerging economies with growing patient populations, increasing adoption of wearable devices, advancements in sensor technologies, and integration of artificial intelligence with RPM serve as opportunities for the market.

Here are the top 10 companies operating in the  Remote Patient Monitoring Market

Medtronic plc (Ireland)

Founded in 1949 and headquartered in Dublin, Ireland, Medtronic is a healthcare technology company engaged in providing services to healthcare systems, physicians, clinicians, and patients. They research, design, manufacture, and sell biomedical engineering products that help alleviate pain, restore health, and extend life.

The company operates through four reportable segments: Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio, and Diabetes Operating Unit. The company operates in the remote patient monitoring market through the Cardiovascular Portfolio and Medical Surgical Portfolio segments.

The company’s products are primarily used in hospitals, surgical centers, and alternate care facilities, such as home care and long-term care facilities. The company markets its products to material managers, group purchasing organizations (GPOs), and integrated delivery networks (IDNs).

The company has a wide geographic presence and offers products in over 150 countries. The company’s four largest markets are the U.S., Western Europe, China, and Japan. Medtronic plc has subsidiaries in Australia, Brazil, the U.S., Canada, China, Egypt, France, Germany, Italy, Mexico, and the Netherlands. Some of its major subsidiaries are Medtronic Australasia Pty Ltd. (Australia), Medtronic BioPharma B.V. (Netherlands), and Medtronic Canada ULC (Canada).

Koninklijke Philips N.V. (Netherlands)

Founded in 1891 and headquartered in Amsterdam, Netherlands, Koninklijke Philips N.V. (Royal Philips) is a health technology company that operates in the healthcare and electronics sectors. The company develops innovative solutions to support healthier lifestyles, prevent diseases, and help people suffering from chronic illness live well at home and in community settings. It also teams up with healthcare providers to innovate, improve, and transform the delivery of care to patients.

The company operates through four reportable segments: Diagnosis & Treatment, Connected Care, Personal Health, and Other. They operate in the remote patient monitoring market through the Connected Care segment. The Connected Care segment is divided into four business divisions: Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care, and Connected Care Informatics. The company operates in the remote patient monitoring market through the Connected Care Informatics business division.

The company has a geographic presence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, specifically in countries such as Australia, Canada, Japan, India, and the U.S. Some of its subsidiaries are Respironics, Inc. (U.S.), Philips do Brasil Ltda. (Brazil), and Philips Medical Systems Technologies Ltd. (Netherlands).

OMRON Corporation (Japan)

Founded in 1933 and headquartered in Kyoto, Japan, OMRON Corporation operates in the field of automation and a broad spectrum of businesses, which include control equipment, electronic components, social systems, and healthcare. The company ventured into healthcare in 2003, when OMRON Healthcare Co., Ltd. was established.

OMRON Corporation manufactures and sells market-leading sensing and control products. The company operates through four business segments: Industrial Automation Business (IAB), Device & Module Solutions Business (DMB), Social Systems, Solutions, and Service Business (SSB), and Healthcare Business (HCB). The company operates in the remote patient monitoring market through the Healthcare Business segment.

The company has a geographic presence in around 120 countries/regions worldwide. Some of its major subsidiaries include OMRON SOCIAL SOLUTIONS Co., Ltd. (Japan), OMRON HEALTHCARE Co., Ltd. (Japan), OMRON Healthcare, Inc. (U.S.), OMRON MANAGEMENT CENTER OF ASIA PACIFIC (Singapore), and OMRON MANAGEMENT CENTER OF EUROPE (Netherlands).

Boston Scientific Corporation (U.S.)

Founded in 1979 and headquartered in Massachusetts, U.S., Boston Scientific Corporation develops, manufactures, and markets medical devices. These medical devices are used in a broad range of interventional medical specialties to provide medical solutions and improve the health of patients around the world. The company develops minimally invasive medical technologies that are considered alternatives to surgery and other medical procedures that may be traumatic to the body.

The company operates through two major segments: MedSurg and Cardiovascular. These two segments are further divided into sub-segments as per the product portfolio. MedSurg is divided into Endoscopy, Urology, and Neuromodulation sub-segments, and the Cardiovascular segment is divided into Cardiology and Peripheral Interventions sub-segments. The company operates in the remote patient monitoring market through the Cardiovascular segment.

The company has a geographic presence in North America, Europe, Asia-Pacific, and Latin America, specifically in countries like Canada, China, the Netherlands, India, Japan, and the U.S. Some of the company’s subsidiaries are Boston Scientific (UK) Limited (U.K.), Boston Scientific AG (Switzerland), Boston Scientific do Brasil Ltda. (Brazil), Boston Scientific India Private Limited. (India), Boston Scientific International S.A. (France), and Apollo Endosurgery, Inc. (U.S.).

Siemens Healthineers AG (Germany)

Founded in 1847 and headquartered in Erlangen, Germany, Siemens Healthineers AG is a global provider of healthcare solutions and services to deliver healthcare solutions and meet the needs of a broad spectrum of healthcare providers. Its extensive product portfolio supports patients throughout their entire care, from prevention and early detection to diagnosis, treatment, and follow-up care.

The company primarily operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. It develops, manufactures, and sells a diverse range of innovative diagnostic and therapeutic products and clinical consulting services.

The company’s key customers include hospitals, hospital systems, public and private clinics and laboratories, universities, physicians/joint medical practices, public health agencies, public and private health insurers, pharmaceutical companies, and clinical research institutes.

The company has a strong presence and is directly represented in more than 70 countries worldwide. Its main production sites are in the U.S., China, and Germany. Some of the company’s subsidiaries are Varian Medical Systems (U.S.), Siemens Medical Solutions USA, Inc. (U.S.), and Siemens Healthineers India LLP (India).

Meticulous Research in its latest publication on Remote Patient Monitoring Market has predicted the growth of 13.7% during the forecast year 2024-2031.

Abbott Laboratories (U.S.)

 Founded in 1888 and headquartered in Illinois, U.S., Abbott Laboratories is a medical device and healthcare company. Their portfolio includes products that range from diagnostics and medical devices to nutrition and branded generic pharmaceuticals.

The company operates in four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company operates in the remote patient monitoring market through the Medical Devices segment. This segment includes a variety of products required for rhythm management, heart devices for cardiovascular diseases, diabetes care products, and neuromodulation devices, which include remote patient monitoring devices.

The company has a geographic presence in Brazil, Canada, Germany, France, India, Japan, and the U.S., among other countries. Some of the subsidiaries of the company include Abbott Cardiovascular Inc. (U.S.), Abbott Diagnostics Rapidos S.A. (Brazil), Abbott International Corporation (Canada), Abbott Laboratories A/S (Denmark), Abbott Medical France SAS (France), Abbott Diagnostics GmbH (Germany), Abbott India Limited (India), Abbott Japan LLC (Japan), and Abbott B.V. (Netherlands).

GE Healthcare Technologies, Inc. (U.S.)

Founded in 1892 and headquartered in Illinois, U.S., GE Healthcare Technologies, Inc. specializes in increasing health system capacity, enhancing productivity, digitizing healthcare delivery, and improving clinical outcomes.

The company’s key customers are healthcare providers, including public, private, and academic institutions. The company operates through four reportable segments: Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The company operates in the remote patient monitoring market through the Patient Care Solutions (PCS) segment.

The company operates in over 160 countries, has R&D facilities in 18 countries, and manufacturing plants in around 20 countries worldwide. Some of the subsidiaries of the company are BK Medical Australia Pty Ltd. (Australia), GE Healthcare Bio-Sciences Company (Canada), China GE Healthcare (China) Co., Ltd. (China), BK Medical Holding Company, Inc. (Delaware), BK Medical France SAS (France), BK Medical Italia S.r.l. (Italy), GE BE Private Ltd (India), and GE Healthcare Bio-Sciences, S.A.U. (Spain).

F. Hoffmann-La Roche AG (Switzerland)

Founded in 1896 and headquartered in Basel, Switzerland, F. Hoffmann-La Roche AG is a pharmaceutical and diagnostics company. It has differentiated medicines for oncology, immunology, infectious disease, ophthalmology, and central nervous system diseases. It also provides in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management.

Roche’s operating segments are organized into two divisions: Pharmaceuticals and Diagnostics. These two segments are divided into sub-segments. The Pharmaceuticals is further segmented into Roche Pharmaceuticals and Chugai, and the Diagnostics segment is divided into the Core Lab, Molecular Lab, Point of Care, Pathology Lab, and Diabetes Care sub-segments.

The company operates in the remote patient monitoring market through the Diagnostics segment and further through the Diabetes Care segment.

The company has a geographic presence across the Americas, Europe, Africa, Asia, and Oceania. The company has 33 research and development sites and 20 manufacturing sites worldwide in the Pharmaceuticals and Diagnostics segments. Some of the company’s subsidiaries include Roche Diabetes Care Austria GmbH (Austria), Roche Diabetes Care Brasil Ltda. (Brazil), Hoffmann-La Roche Limited (Canada), Roche Diagnostics [Hongkong] Limited (China), Roche Pharmaceuticals A/S (Denmark), Roche Diabetes Care France SAS (France), Roche Diabetes Care Deutschland GmbH (Germany), and Roche Diabetes Care India Private Limited (India).

Baxter International, Inc. (U.S.)

 Founded in 1931 and headquartered in Illinois, U.S., Baxter International Inc. is a multinational healthcare company that provides a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices.

The company’s key customers are hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and patients at home under physician supervision.

In the third quarter of 2023, the company implemented a new operating model to streamline operations and align its manufacturing and supply chain to commercial sites. The company used to operate globally through four reportable segments: Americas (North and South America), EMEA (Europe, Middle East, and Africa), and a global segment called Hillrom, which Baxter acquired in December 2021.

However, now, the company operates through the following segments: Medical Products and Therapies, Healthcare Systems and Technologies (Former Hillrom segment), Pharmaceuticals, and Kidney Care.

The company operates in the remote patient monitoring market through the Healthcare Systems and Technologies segment. This segment provides products and services to help with early diagnosis and treatment, optimizing surgical efficiency.

The company has distribution facilities in the U.S., Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Spain, and the U.K.

Some of the company’s subsidiaries include Baxter Healthcare Pty Ltd. (Australia), Baxter Hospitalar Ltda. (Brazil), Baxter Corporation (Canada), Baxter Healthcare [Shanghai] Company Ltd. (China), Baxter Healthcare Corporation (Delaware), Baxter SAS (France), Baxter Deutschland GmbH (Germany), Baxter [India] Private Limited (India), and Baxter S.p.A (Italy).

DexCom, Inc. (U.S.)

Founded in 1999 and headquartered in California, U.S., DexCom, Inc., is a medical device company that specializes in designing, developing, and commercializing continuous glucose monitoring (CGM) systems for patients with diabetes and healthcare providers. The company has a direct sales organization in North America and certain international markets.

The company has additional offices across Asia, Europe, and the U.S. Some of its subsidiaries include Nintamed Handels GmbH (Austria), DexCom Canada, Co. (Canada), SweetSpot Diabetes Care, Inc. (Delaware), DexCom Deutschland GmbH (Germany), DexCom Asia Pacific Operations PTE Ltd. (Singapore), and DexCom International Ltd. (U.K.).

Authoritative Research on the Remote Patient Monitoring Market – Global Opportunity Analysis and Industry Forecast (2024-2031)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

• Recent financial performance
• Key products
• Significant company strategies
• Partnerships and acquisitions

The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.